The United Laboratories International Holdings Limited (HKG:3933)
7.93
-0.07 (-0.81%)
Sep 23, 2026, 4:08 PM HKT
HKG:3933 Market Cap
HKG:3933 has a market cap or net worth of 15.58 billion as of September 23, 2026. Its market cap has decreased by -49.54% in one year.
Market Cap
15.58B
Enterprise Value
9.76B
Revenue
13.69B
Ranking
n/a
PE Ratio
25.00
Stock Price
7.93
ChartMarket Cap Chart
Since June 15, 2007, HKG:3933's market cap has increased from 4.33B to 15.58B, an increase of 259.62%. That is a compound annual growth rate of 6.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 15.58B | -31.87% |
| Dec 31, 2025 | 22.87B | 1.82% |
| Dec 31, 2024 | 22.46B | 76.32% |
| Dec 29, 2023 | 12.74B | 43.06% |
| Dec 30, 2022 | 8.90B | 11.62% |
| Dec 31, 2021 | 7.98B | -21.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simcere Pharmaceutical Group | 28.69B |
| China Resources Pharmaceutical Group | 27.33B |
| China Medical System Holdings | 26.93B |
| Sunshine Lake Pharma | 20.94B |
| Grand Pharmaceutical Group | 17.11B |
| Fujian Haixi Pharmaceuticals | 15.17B |
| CanSino Biologics | 12.61B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |